Parvovirus B19 infection and unresponsiveness to erythropoietin therapy in haemodialysis patients.
Duranay
M
M
Department of Nephrology, University of Inonü, Malatya, Turkey.
Bali
M
M
Sahin
M
M
Yakinci
G
G
Vurgun
N
N
Dilmen
U
U
D000293:Adolescent; D000741:Anemia, Aplastic / Q000150:complications / Q000821:virology; D003692:Delayed-Action Preparations / Q000627:therapeutic use; D004921:Erythropoietin / Q000627:therapeutic use*; D005296:Ferrous Compounds / Q000627:therapeutic use; D005921:Glomerulonephritis / Q000150:complications / Q000628:therapy; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D008297:Male; D010322:Parvoviridae Infections / Q000150:complications* / Q000188:drug therapy; D016732:Parvovirus B19, Human; D006435:Renal Dialysis; D014511:Uremia / Q000150:complications
D003692:Delayed-Action Preparations; D005296:Ferrous Compounds; D004921:Erythropoietin; C020748:ferrous sulfate